Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872518 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusion: Women with pT1-T2N0 breast cancer experienced a LRR risk of approximately 20% in the presence of Grade 3 disease with LVI or Grade 3 disease, T2 tumors, and no systemic therapy. These subsets of node-negative patients warrant consideration of for postmastectomy radiotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Pauline T. M.D., C.M., Mary Ph.D., Aydin B.Sc., Hosam A. M.B., B.S., Caroline H. B.A., Ivo. A. M.D.,